← Eichor
Study identifier: NCT07391930 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

High-Intensity Interval Training and Menstrual Health Experience in Primary Dysmenorrhea.

Condition: Dysmenorrhea Primary · Menstrual Pain · Pelvic Pain  ·  Sponsor: University of Alcala

PhaseNA
Planned participants60
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersNo

About this study

The goal of this study is to evaluate whether a 12-week online supervised high-intensity interval training program can reduce menstrual pain and improve quality of life in women with primary dysmenorrhea. Participants will be divided into two groups: one receiving an educational workshop and the HIIT program, and a control group receiving only the workshop. Additionally, the study seeks to understand the personal experience of these women through weekly health diaries, exploring how the intervention affects their relationship with their bodies and their menstruation. The ultimate goal is to offer new, non-pharmacological evidence-based tools for managing menstrual pain.

This description comes directly from the study's public registry record.

Talk to the study team

Esther M Pindado Perez, PhD Student  ·  +34 689714447  ·  esther.pindado@edu.uah.es

Always discuss trial participation with your own doctor first.

Locations (1)

Universidad de Alcalá, Facultad de Enfermeria y FisioterapiaAlcalá de Henares, Madrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07391930